Literature DB >> 29180385

Treatment of venous thromboembolism in a 22-year-old woman taking an oral contraceptive pill.

Daniel M Shafran1, Cynthia Wu2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29180385      PMCID： PMC5703678          DOI： 10.1503/cmaj.170398

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  11 in total

1.  Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.

Authors:  Harry R Büller; Hervé Décousus; Michael A Grosso; Michele Mercuri; Saskia Middeldorp; Martin H Prins; Gary E Raskob; Sebastian M Schellong; Lee Schwocho; Annelise Segers; Minggao Shi; Peter Verhamme; Phil Wells
Journal:  N Engl J Med       Date:  2013-08-31       Impact factor: 91.245

Review 2.  Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy.

Authors:  Ian A Greer; Catherine Nelson-Piercy
Journal:  Blood       Date:  2005-04-05       Impact factor: 22.113

3.  Abnormal vaginal bleeding in women with venous thromboembolism treated with apixaban or warfarin.

Authors:  Marjolein P A Brekelmans; Luuk J J Scheres; Suzanne M Bleker; Barbara A Hutten; Anne Timmermans; Harry R Büller; Saskia Middeldorp
Journal:  Thromb Haemost       Date:  2017-02-09       Impact factor: 5.249

4.  Oral rivaroxaban for the treatment of symptomatic pulmonary embolism.

Authors:  Harry R Büller; Martin H Prins; Anthonie W A Lensin; Hervé Decousus; Barry F Jacobson; Erich Minar; Jaromir Chlumsky; Peter Verhamme; Phil Wells; Giancarlo Agnelli; Alexander Cohen; Scott D Berkowitz; Henri Bounameaux; Bruce L Davidson; Frank Misselwitz; Alex S Gallus; Gary E Raskob; Sebastian Schellong; Annelise Segers
Journal:  N Engl J Med       Date:  2012-03-26       Impact factor: 91.245

5.  Oral apixaban for the treatment of acute venous thromboembolism.

Authors:  Giancarlo Agnelli; Harry R Buller; Alexander Cohen; Madelyn Curto; Alexander S Gallus; Margot Johnson; Urszula Masiukiewicz; Raphael Pak; John Thompson; Gary E Raskob; Jeffrey I Weitz
Journal:  N Engl J Med       Date:  2013-07-01       Impact factor: 91.245

Review 6.  Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism.

Authors:  Marc Carrier; Grégoire Le Gal; Philip S Wells; Marc A Rodger
Journal:  Ann Intern Med       Date:  2010-05-04       Impact factor: 25.391

7.  Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use.

Authors:  Ida Martinelli; Anthonie W A Lensing; Saskia Middeldorp; Marcel Levi; Jan Beyer-Westendorf; Bonno van Bellen; Henri Bounameaux; Timothy A Brighton; Alexander T Cohen; Mila Trajanovic; Martin Gebel; Phuong Lam; Philip S Wells; Martin H Prins
Journal:  Blood       Date:  2015-12-22       Impact factor: 22.113

8.  Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.

Authors:  Clive Kearon; Elie A Akl; Joseph Ornelas; Allen Blaivas; David Jimenez; Henri Bounameaux; Menno Huisman; Christopher S King; Timothy A Morris; Namita Sood; Scott M Stevens; Janine R E Vintch; Philip Wells; Scott C Woller; Lisa Moores
Journal:  Chest       Date:  2016-01-07       Impact factor: 9.410

9.  Dabigatran versus warfarin in the treatment of acute venous thromboembolism.

Authors:  Sam Schulman; Clive Kearon; Ajay K Kakkar; Patrick Mismetti; Sebastian Schellong; Henry Eriksson; David Baanstra; Janet Schnee; Samuel Z Goldhaber
Journal:  N Engl J Med       Date:  2009-12-10       Impact factor: 91.245

10.  Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism.

Authors:  Richard H White; Wee-Shian Chan; Hong Zhou; Jeffrey S Ginsberg
Journal:  Thromb Haemost       Date:  2008-08       Impact factor: 5.249
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.